HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors-Reference-Cited by-同舟云学术

HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors

Published:2015-12-20 Issue:2 Volume:46 Page:409-419
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Sottile Rosa¹²,Pangigadde Pradeepa N.¹²,Tan Thomas³,Anichini Andrea⁴,Sabbatino Francesco⁵,Trecroci Francesca²,Favoino Elvira⁵,Orgiano Laura³,Roberts James³,Ferrone Soldano⁵,Kärre Klas¹,Colucci Francesco³,Carbone Ennio¹²

Affiliation:

1. Department of Microbiology; Tumor and Cell Biology; Karolinska Institute Stockholm Sweden

2. University Magna Graecia of Catanzaro; Catanzaro Italy

3. Department of Obstetrics and Gynaecology; University of Cambridge School of Clinical Medicine; NIHR Cambridge Biomedical Research Centre; Cambridge UK

4. Department of Experimental Oncology and Molecular Medicine; Fondazione IRCCS Istituto Nazionale dei Tumori; Milan Italy

5. Massachusetts General Hospital; Harvard Medical School; Boston MA USA

Funder

UICC International Cancer Technology Transfer Fellowship and Italian Ministry of Health

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference50 articles.

1. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

2. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N. Engl. J. Med.,2011

3. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial;Hauschild;Lancet,2012

4. Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma;Trunzer;J. Clin. Oncol.,2013

5. Immune modulation in cancer with antibodies;Page;Annu. Rev. Med.,2014

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into immune cells modulation of tumor resistance;Critical Reviews in Oncology/Hematology;2024-10

2. CAR NK Cell Therapy for the Treatment of Metastatic Melanoma: Potential & Prospects;Cells;2023-11-30

3. Circulating Natural Killer Cells as Prognostic Value for Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Correlation with Sarcopenia;Cancers;2023-07-12

4. Enhanced development of functional human NK cells in NOD‐ scid‐IL2rg ^null mice expressing human IL15;The FASEB Journal;2022-08-12

5. BRAF inhibitors and their immunological effects in malignant melanoma;Expert Review of Clinical Immunology;2022-03-03